Clinical Trial Update: Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating selective estrogen receptor modulators to enhance the reactivation of latent HIV using histone deacetylase inhibitors; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2019-12-18